Patents by Inventor Giampietro Ventresca

Giampietro Ventresca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treatment of eosinophilic bronchitis with an anti-IL-5 antibody
    Patent number: 11325972
    Abstract: The present invention relates generally to the methods for the treatment and diagnosis of conditions mediated by IL-5 and excess eosinophil production, and more specifically to mAbs, Fabs, chimeric and humanized antibodies. More particularly, the present invention relates generally to the treatment of eosinophilic bronchitis with an anti-IL-5 antibody or fragment thereof.
    Type: Grant
    Filed: September 19, 2019
    Date of Patent: May 10, 2022
    Assignee: GLAXOSMITHKLINE LLC
    Inventors: Fredrick E. Hargreave, Giampietro Ventresca
  • METHODS OF TREATMENT
    Publication number: 20200071395
    Abstract: The present invention relates generally to the methods for the treatment and diagnosis of conditions mediated by IL-5 and excess eosinophil production, and more specifically to mAbs, Fabs, chimeric and humanized antibodies. More particularly, the present invention relates generally to the treatment of eosinophilic bronchitis with an anti-IL-5 antibody or fragment thereof.
    Type: Application
    Filed: September 19, 2019
    Publication date: March 5, 2020
    Inventors: Fredrick E. HARGREAVE, Giampietro VENTRESCA
  • METHODS OF TREATMENT OF EOSINOPHILIC BRONCHITIS WITH AN ANTI-IL-5 ANTIBODY
    Publication number: 20180057582
    Abstract: The present invention relates generally to the methods for the treatment and diagnosis of conditions mediated by IL-5 and excess eosinophil production, and more specifically to mAbs, Fabs, chimeric and humanized antibodies. More particularly, the present invention relates generally to the treatment of eosinophilic bronchitis with an anti-IL-5 antibody or fragment thereof.
    Type: Application
    Filed: November 6, 2017
    Publication date: March 1, 2018
    Inventors: Fredrick E. HARGREAVE, Giampietro Ventresca
  • Methods of treatment of eosinophilic bronchitis with an anti-IL-5 antibody
    Patent number: 9834600
    Abstract: The present invention relates generally to the methods for the treatment and diagnosis of conditions mediated by IL-5 and excess eosinophil production, and more specifically to mAbs, Fabs, chimeric and humanized antibodies. More particularly, the present invention relates generally to the treatment of eosinophilic bronchitis with an anti-IL-5 antibody or fragment thereof.
    Type: Grant
    Filed: March 27, 2009
    Date of Patent: December 5, 2017
    Assignee: GlaxoSmithKline LLC
    Inventors: Fredrick E. Hargreave, Giampietro Ventresca
  • METHODS OF TREATMENT
    Publication number: 20110020339
    Abstract: The present invention relates generally to the methods for the treatment and diagnosis of conditions mediated by IL-5 and excess eosinophil production, and more specifically to mAbs, Fabs, chimeric and humanized antibodies. More particularly, the present invention relates generally to the treatment of eosinophilic bronchitis with an anti-IL-5 antibody or fragment thereof.
    Type: Application
    Filed: March 27, 2009
    Publication date: January 27, 2011
    Inventors: Fredrick E. Hargreave, Giampietro Ventresca